It is a pharma private limited company based in Andhra Pradesh, Telangana, India, established in 2003.
2003 | Andhra Pradesh, Telangana, India | ActiveBridge Pharmaceuticals Private Limited, a active private limited company, was established on 11 September 2003 in Andhra Pradesh, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239TG2003PTC041672. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Bomma Sowjanya (Managing Director), Kistam Vijayalaxmi (Director). Past directors included Vasudevarao Dandamudi, Medarametla Sambasiva Rao, Raj Nandan Reddy Chinnapolu. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No.89, Prashanthi Nagar ,Ida, Kukatpally, Hyderabad-072, Andhra Pradesh, Telangana, 500072.
U24239TG2003PTC041672
041672
11 September 2003
₹0.50 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Bridge Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bomma Sowjanya | Managing Director | 19 Mar 2022 | Current |
| Kistam Vijayalaxmi | Director | 19 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2012 | Past |
| Pramod Abcsdd | Director | 06 May 2022 | Past |
| Pramod Abcsdd | Director | 06 May 2022 | Past |
| Pramod Abcsdd | Director | 23 Jun 2021 | Past |
| Pramod Abcsdd | Director | 13 Jun 2021 | Past |
| Pramod Abcsdd | Additional Director | 28 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bridge Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 55.91% increase. The company also saw a substantial improvement in profitability, with a 66.63% increase in profit. The company's net worth moved up by a moderate rise of 6.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Bridge Pharmaceuticals had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bridge Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bridge Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bridge Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bomma Sowjanya was appointed as a Managing Director was appointed as a Managing Director on 19 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
The activity Kistam Vijayalaxmi was appointed as a Director was appointed as a Director on 19 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
Progress on Bridge Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
The activity Bridge Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Hyderabad. was completed.
The activity Bridge Pharmaceuticals Private Limited was registered on 11 Sep 2003 with Roc Hyderabad & aged 22 years 2 months as per MCA records. was completed.
The CIN of Bridge Pharmaceuticals Private Limited is U24239TG2003PTC041672.
Bridge Pharmaceuticals Private Limited is headquartered at Plot No.89, Prashanthi Nagar ,Ida, Kukatpally, Hyderabad-072, Andhra Pradesh, Telangana, 500072.
Bridge Pharmaceuticals Private Limited was incorporated on 11 September 2003.
The current directors of Bridge Pharmaceuticals Private Limited are
The primary industry of Bridge Pharmaceuticals Private Limited is Pharma.
Bridge Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bridge Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Bridge Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX